Chymopapain and method of purifying it on an inhibitory dipeptide affinity column
US5380656A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 13, 1991 |
| Grant date | Jan 10, 1995 |
| Priority date | — |
| Expiry date | Dec 13, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of purifying chymopapain by active site directed affinity chromatography using inhibitory dipeptides as affinity ligands is presented. The inhibitory dipeptides have C-terminal aldehyde derivatives of phenylalanine selected from the group consisting of the semicarbazone, the methoxyimine and the oxime. The purified chymopapain has a specific activity against BAPNA (1 mM) at 40.degree. C. and pH 6.8 of between 3000 and 4500 units per mg and contains less than 0.2% each of papaya proteinase III (PPIII), papain and papaya proteinase IV (PPIV). The use of purified chymopapain in pharmaceutical compositions for the treatment of damaged mammalian spinal discs is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.